secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2023-09-11T23:59:59+00:00
Accession:  0000064803-23-000036
Event type: earnings
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health reaffirms FY2023 GAAP EPS $6.53-$6.75, Adjusted EPS $8.50-$8.70, CFO $12.5B-$13.5B
--------------------------------------------------------------------------------

- Reaffirms FY2023 GAAP diluted EPS range $6.53–$6.75, unchanged from prior guidance.
- Reaffirms FY2023 Adjusted EPS range $8.50–$8.70, unchanged.
- Reaffirms FY2023 cash flow from operations guidance $12.5B–$13.5B.
- Management to present at investor meeting on September 12, 2023; webcast available.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000036/0000064803-23-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000006480323000036/cvs-20230911.htm
  HTML page:      https://secwatch.observer/filing/0000064803-23-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer